GlassScriptPhysician profile
James G Mcpherson
NPI 1639185887
$92,530.62
in general payments reported to CMS, 2019-2025
36 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,483 · 2020: $3,718 · 2021: $18K · 2022: $15K · 2023: $12K · 2024: $21K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $36K · Education: $5,545 · Food and Beverage: $3,293 · Travel and Lodging: $1,828 · Consulting Fee: $1,628 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $450 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $35,920.00 |
| Education | $5,544.50 |
| Food and Beverage | $3,292.98 |
| Travel and Lodging | $1,827.91 |
| Consulting Fee | $1,627.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $450.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $46,616.20 | 2020-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Intuitive Surgical, INC. | $17,978.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $15,606.01 | 2019-2025 | Tagrisso |
| Atricure, INC. | $2,718.62 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Davol INC. | $1,501.25 | 2019-2025 | Progel Applicator Spray Tips, Channel Drain |
| Cerus Corporation | $1,500.00 | 2019 | |
| Edwards Lifesciences Corporation | $1,069.94 | 2019-2023 | Inspiris Resilia Aortic Valve |
| Abiomed | $982.27 | 2019 | |
| Medtronic Vascular, INC. | $663.75 | 2019-2020 | |
| Medtronic, INC. | $578.74 | 2021-2023 | Endurant Iis |
| Galvanize Therapeutics, INC | $513.60 | 2023-2025 | Aliya System |
| Biom'Up Sa | $403.78 | 2019 | |
| La Jolla Pharmaceutical Company | $368.93 | 2019-2021 | |
| Boston Scientific Corporation | $244.25 | 2019-2021 | |
| Abbott Laboratories | $225.43 | 2021-2023 | Epic |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $173.03 | 2019-2020 | |
| Biom'Up France Sas | $171.01 | 2020 | |
| Kls-Martin L.P. | $168.82 | 2019-2021 | |
| Telix Pharmaceuticals | $151.33 | 2025 | Illuccix |
| W. L. Gore & Associates, INC. | $149.31 | 2019 | |
| Chiesi USA, INC. | $114.56 | 2020 | |
| Pinnacle Biologics, INC | $100.37 | 2019-2020 | |
| Getinge USA Sales, LLC | $90.23 | 2019-2020 | |
| Inari Medical, INC. | $79.80 | 2022 | |
| Ethicon US, LLC | $63.25 | 2020-2025 | Stratafix, Ethicon, Surgicel Nu-Knit |
| Livanova USA, INC. | $39.77 | 2019 | |
| Grifols USA, LLC | $39.49 | 2019-2020 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $39.12 | 2025 | |
| Novo Nordisk INC | $30.98 | 2024-2025 | Wegovy |
| Rigel Pharmaceuticals, INC. | $28.67 | 2019 | |
| Artivion, INC. | $28.50 | 2019 | |
| Acera Surgical, INC. | $25.01 | 2025 | Restrata Wound Matrix |
| Baxter Healthcare | $19.43 | 2019 | |
| Merck Sharp & Dohme LLC | $19.25 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.45 | 2021 | |
| Covidien LP | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcpherson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.